These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1410 related articles for article (PubMed ID: 7774847)
1. Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study. Eddy GL; Manetta A; Alvarez RD; Williams L; Creasman WT Gynecol Oncol; 1995 Jun; 57(3):412-6. PubMed ID: 7774847 [TBL] [Abstract][Full Text] [Related]
2. Treatment of ("bulky") stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group. Eddy GL; Bundy BN; Creasman WT; Spirtos NM; Mannel RS; Hannigan E; O'Connor D Gynecol Oncol; 2007 Aug; 106(2):362-9. PubMed ID: 17493669 [TBL] [Abstract][Full Text] [Related]
4. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza. Zanetta G; Fei F; Mangioni C Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040 [TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in patients with bulky stage IB or IIA cervical carcinoma undergoing neoadjuvant chemotherapy and radical hysterectomy. Lai CH; Hsueh S; Chang TC; Tseng CJ; Huang KG; Chou HH; Chen SM; Chang MF; Shum HC Gynecol Oncol; 1997 Mar; 64(3):456-62. PubMed ID: 9062150 [TBL] [Abstract][Full Text] [Related]
6. Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB-IIA cervical cancer. Takeshima N; Umayahara K; Fujiwara K; Hirai Y; Takizawa K; Hasumi K Gynecol Oncol; 2006 Nov; 103(2):618-22. PubMed ID: 16777200 [TBL] [Abstract][Full Text] [Related]
7. Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial. Monk BJ; Wang J; Im S; Stock RJ; Peters WA; Liu PY; Barrett RJ; Berek JS; Souhami L; Grigsby PW; Gordon W; Alberts DS; ; ; Gynecol Oncol; 2005 Mar; 96(3):721-8. PubMed ID: 15721417 [TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant intraarterial chemotherapy followed by radical hysterectomy and/or radiotherapy for locally advanced cervical cancer. Sugiyama T; Nishida T; Hasuo Y; Fujiyoshi K; Yakushiji M Gynecol Oncol; 1998 May; 69(2):130-6. PubMed ID: 9600820 [TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemotherapy and conservative surgery for stage IB1 cervical cancer. Maneo A; Chiari S; Bonazzi C; Mangioni C Gynecol Oncol; 2008 Dec; 111(3):438-43. PubMed ID: 18835493 [TBL] [Abstract][Full Text] [Related]
10. Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy. Hwang YY; Moon H; Cho SH; Kim KT; Moon YJ; Kim SR; Kim DS Gynecol Oncol; 2001 Jul; 82(1):88-93. PubMed ID: 11426967 [TBL] [Abstract][Full Text] [Related]
11. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion. Huguet F; Cojocariu OM; Levy P; Lefranc JP; Darai E; Jannet D; Ansquer Y; Lhuillier PE; Benifla JL; Seince N; Touboul E Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1508-15. PubMed ID: 18676093 [TBL] [Abstract][Full Text] [Related]
12. Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy. Gadducci A; Teti G; Barsotti C; Tana R; Fanucchi A; Orlandini C; Fabrini MG; Genazzani AR Anticancer Res; 2010 Jan; 30(1):201-8. PubMed ID: 20150636 [TBL] [Abstract][Full Text] [Related]
13. Pilot study on induction chemotherapy with cisplatin, epirubicin, etoposide and bleomycin in cervical cancer stage Ib, IIa and IIb. Panetta A; Angelelli B; Martoni A Anticancer Res; 1999; 19(1B):765-8. PubMed ID: 10216490 [TBL] [Abstract][Full Text] [Related]
14. Comparative study of bulky stage IB and IA cervical cancer patients treated by radical hysterectomy with and without neoadjuvant chemotherapy: long-term follow-up. Manusirivithaya S; Chareoniam V; Pantusart A; Isariyodom P; Srisomboon J J Med Assoc Thai; 2001 Nov; 84(11):1550-7. PubMed ID: 11853297 [TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy and radical surgery compared to radical surgery alone in bulky stage IB-IIA cervical cancer. Behtash N; Nazari Z; Ayatollahi H; Modarres M; Ghaemmaghami F; Mousavi A Eur J Surg Oncol; 2006 Dec; 32(10):1226-30. PubMed ID: 16952434 [TBL] [Abstract][Full Text] [Related]
16. Adjuvant small field pelvic radiation for patients with high risk, stage IB lymph node negative cervix carcinoma after radical hysterectomy and pelvic lymph node dissection. A pilot study. Kridelka FJ; Berg DO; Neuman M; Edwards LS; Robertson G; Grant PT; Hacker NF Cancer; 1999 Nov; 86(10):2059-65. PubMed ID: 10570432 [TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up after neoadjuvant chemotherapy for high-risk cervical cancer during pregnancy. Bader AA; Petru E; Winter R Gynecol Oncol; 2007 Apr; 105(1):269-72. PubMed ID: 17289127 [TBL] [Abstract][Full Text] [Related]
18. Chemotherapy with cisplatin and paclitaxel in locally advanced cervical cancer: has this regimen still a role as neoadjuvant setting? Moioli M; Papadia A; Mammoliti S; Pacella E; Menoni S; Menada MV; Ragni N Minerva Ginecol; 2012 Apr; 64(2):95-107. PubMed ID: 22481620 [TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemotherapy followed by radical surgery and radiotherapy vs. pelvic irradiation in patients with cervical cancer FIGO stage IIB - IVA. Kornovski Y; Gorchev G J BUON; 2006; 11(3):291-7. PubMed ID: 17309152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]